102 related articles for article (PubMed ID: 28326574)
1. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC.
Chen S; Liao C; Hu H; Liao J; Chen Z; Li S; Zeng X; Peng B; Shen S; Li D; Li S; Lai J; Peng S; Xie Y; Kuang M
Hepatology; 2024 Apr; 79(4):780-797. PubMed ID: 37725755
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and molecular analysis of lymphocyte-rich hepatocellular carcinoma.
Tsutsui K; Nakayama M; Ogasawara S; Akiba J; Kondo R; Mihara Y; Yano Y; Mizuochi S; Kinjo Y; Murotani K; Yano H
Hum Pathol; 2023 Nov; 141():43-53. PubMed ID: 37742944
[TBL] [Abstract][Full Text] [Related]
4. Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas.
Öztürk B
Cureus; 2023 Dec; 15(12):e50795. PubMed ID: 38116022
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT/TGFB signatures, associated with poor outcome.
Desert R; Chen W; Ge X; Viel R; Han H; Athavale D; Das S; Song Z; Lantvit D; Cano L; Naba A; Musso O; Nieto N
Hepatology; 2023 Sep; 78(3):741-757. PubMed ID: 36999534
[TBL] [Abstract][Full Text] [Related]
6. Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment.
Toshida K; Itoh S; Iseda N; Tomiyama T; Yoshiya S; Toshima T; Liu YC; Iwasaki T; Okuzaki D; Taniguchi K; Oda Y; Mori M; Yoshizumi T
Liver Int; 2024 Apr; 44(4):1011-1023. PubMed ID: 38293713
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B; Konjeti VR; Ditah I
Gastrointest Cancer Res; 2014 Mar; 7(2):49-54. PubMed ID: 24799971
[TBL] [Abstract][Full Text] [Related]
8. Anti-stromal nanotherapeutics for hepatocellular carcinoma.
Yu Z; Huang L; Guo J
J Control Release; 2024 Mar; 367():500-514. PubMed ID: 38278367
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar hepatocellular carcinoma: a case report and gene analysis.
Watanabe A; Harimoto N; Saito H; Kawabata-Iwakawa R; Seki T; Muranushi R; Hoshino K; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Ikota H; Ishige T; Mimori K; Shirabe K
Surg Case Rep; 2023 Sep; 9(1):168. PubMed ID: 37728655
[TBL] [Abstract][Full Text] [Related]
10. [Contrast-Enhanced Ultrasound of Fibrolamellar Hepatocellular Carcinoma].
Wildner D; Schlitt HJ; Bäuerle T; Haibach M
Z Gastroenterol; 2023 Dec; 61(12):1618-1622. PubMed ID: 37309100
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Locoregional Therapy May Relate with Stemness and Distinct Transitions Between Epithelial and Mesenchymal States in Hepatocellular Carcinoma.
Espírito Santo J; Ladeirinha A; Alarcão A; Strelet E; Reis M; Santos R; Carvalho L
J Clin Exp Hepatol; 2024; 14(1):101268. PubMed ID: 38076372
[TBL] [Abstract][Full Text] [Related]
12. Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters.
Shigematsu Y; Tanaka K; Amori G; Kanda H; Takahashi Y; Takazawa Y; Takeuchi K; Inamura K
Hepatol Res; 2024 Apr; 54(4):368-381. PubMed ID: 37950386
[TBL] [Abstract][Full Text] [Related]
13. Research Progress on the Role and Mechanism of IL-37 in Liver Diseases.
Jiang B; Zhou Y; Liu Y; He S; Liao B; Peng T; Yao L; Qi L
Semin Liver Dis; 2023 Aug; 43(3):336-350. PubMed ID: 37582401
[TBL] [Abstract][Full Text] [Related]
14. Spatial transcriptomic interrogation of the tumour-stroma boundary in a 3D engineered model of ameloblastoma.
Bakkalci D; Al-Badri G; Yang W; Nam A; Liang Y; Khurram SA; Heavey S; Fedele S; Cheema U
Mater Today Bio; 2024 Feb; 24():100923. PubMed ID: 38226014
[TBL] [Abstract][Full Text] [Related]
15. Scirrhous HCC: Another 'omic thread in the HCC tapestry.
Franses JW; Duda DG
Hepatology; 2024 Apr; 79(4):747-748. PubMed ID: 37725712
[No Abstract] [Full Text] [Related]
16. Case of Abdominal Tumour (Fibro-scirrhous) Connected with the Uterus.
Pennock CW
Med Exam (Phila); 1839 Jul; 2(30):469-473. PubMed ID: 38118867
[No Abstract] [Full Text] [Related]
17. A personalized approach for tumour biopsy in hepatocellular carcinoma.
Ronot M; Nault JC
JHEP Rep; 2024 Apr; 6(4):100979. PubMed ID: 38510982
[No Abstract] [Full Text] [Related]
18. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
19. Intracranial metastasis in fibrolamellar hepatocellular carcinoma.
Hammond WJ; Lalazar G; Saltsman JA; Farber BA; Danzer E; Sherpa TC; Banda CD; Andolina JR; Karimi S; Brennan CW; Torbenson MS; La Quaglia MP; Simon SM
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286561
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
